- ICH GCP
- Registro de ensayos clínicos de la UE
Últimos ensayos
EudraCT Number: 2006-004007-19 | Sponsor Protocol Number: AV-007-IM | Start Date: 2006-11-16 | |||||||||||
Sponsor Name: Nycomed Austria GmbH | |||||||||||||
Full Title: A multi-centre, double-blind, placebo-controlled, randomised, parallel group clinical trial to evaluate efficacy and safety of Actovegin® in diabetic type 2 patients with symptomatic diabetic perip... | |||||||||||||
Medical condition: Diabetic Polyneuropathy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005291-41 | Sponsor Protocol Number: BIOC/AMBV/906 | Start Date: 2006-11-16 | |||||||||||
Sponsor Name: CYATHUS Exquirere PharmaforschungsGmbH | |||||||||||||
Full Title: A single center, open, pilot study to evaluate the pharmacokinetic profile of a new galenic formulation of an Ambroxol-Hydrochloride (Ambroxol-HCl) spray: Ambroxol “CYATHUS” 50 mg/mL Oral Spray, ad... | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001657-94 | Sponsor Protocol Number: SPCG 13 | Start Date: 2006-11-16 | |||||||||||
Sponsor Name: [...] 1. 2. Scandinavian Prostate Cancer Group/ P.O. Hedlund | |||||||||||||
Full Title: Randomized adjuvant phase III trial of six cycles of docetaxel+hormonal treatment versus hormonal treatment in patients with intermediate or high-risk prostate cancer treated with radical radiothe... | |||||||||||||
Medical condition: Intermediate or high-risk prostate cancer treated with radical radiotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FI (Ongoing) IE (Completed) SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004565-33 | Sponsor Protocol Number: EASI | Start Date: 2006-11-16 | |||||||||||
Sponsor Name: Chemische Fabrik Kreussler & Co.GmbH | |||||||||||||
Full Title: Efficacy and safety of Aethoxysklerol compared to Sodium Tetradecyl Sulfate and Isotonic Saline (placebo) for the treatment of reticular veins and spider veins including subgroup to investigate the... | |||||||||||||
Medical condition: Patients suffering from varicose veins (spider veins or reticular veins in the legs) should be treated with a sclerosing agent. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005203-33 | Sponsor Protocol Number: V87P3 | Start Date: 2006-11-16 | ||||||
Sponsor Name: Novartis Vaccines and Diagnostics GmbH & Co. KG | ||||||||
Full Title: A Phase II, Multicenter, Exploratory Study to Evaluate Safety and Immunogenicity of Two Doses of FLUAD-H5N1 Influenza Vaccine in Adults Unprimed and Primed with MF59-adjuvanted or Non-adjuvanted H5... | ||||||||
Medical condition: avian influenza | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2006-004561-34 | Sponsor Protocol Number: 4.2006.1285 | Start Date: 2006-11-16 | ||||||
Sponsor Name: St. Olavs Hospital | ||||||||
Full Title: Tranexamic acid to elderly patients undergoing combined AVR and CABG surgery. | ||||||||
Medical condition: We will investigate whether tranexamic acid given as a bolus injection at the start of surgery followed by a continuous infusion during surgery reduces postoperative bleeding in patients above 70 y... | ||||||||
|
||||||||
Population Age: Elderly | Gender: Male, Female | |||||||
Trial protocol: NO (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002832-93 | Sponsor Protocol Number: TaxAlim01 | Start Date: 2006-11-16 | ||||||
Sponsor Name: Städt. Krankenhaus Martha Maria Halle | ||||||||
Full Title: Phase I/II-Studie Kombinationschemotherapie mit Docetaxel und Pemetrexed in der 2nd line-Therapie bei Patienten mit NSCLC, Stadium IIIB und IV | ||||||||
Medical condition: Nichtkleinzelliges Bronchialkarzinom, Stadium IIIB und IV | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2006-004003-18 | Sponsor Protocol Number: CLDT600A2406 | Start Date: 2006-11-16 | |||||||||||
Sponsor Name: Novartis Pharma Services AG | |||||||||||||
Full Title: A randomized, open-label, controlled, mutli-center two-year study comparing efficacy and safety of telbivudine 600mg PO in combination with peg alpha-2a 180 µg with peg alpha-2a montherapy, and wit... | |||||||||||||
Medical condition: Treatment of naïve patients with HBeAg-positive compensated chronic hepatitis B | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) FR (Prematurely Ended) IT (Completed) DE (Prematurely Ended) BE (Completed) NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003571-12 | Sponsor Protocol Number: GLU0409 | Start Date: 2006-11-15 | ||||||
Sponsor Name: Barts and the London NHS Trust | ||||||||
Full Title: Breath Methionine and Other Indices of Oxidant Stress in the Critical Care Setting. The effect of two doses of Dipeptiven given independently of parenteral nutrition. | ||||||||
Medical condition: 60 consecutive critically ill patients will be recruited with illnesses such as severe infection, trauma and post-surgery. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2006-005635-25 | Sponsor Protocol Number: 1395 | Start Date: 2006-11-15 | |||||||||||
Sponsor Name: POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Postoperative pain after cesarean section :efficacy of S-ketamine at antihyperalgesic doses. | |||||||||||||
Medical condition: Postoperative pain after cesarean section | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |